Importer of Controlled Substances Application: Purisys, LLC, 14471-14472 [2021-05356]

Download as PDF 14471 Federal Register / Vol. 86, No. 49 / Tuesday, March 16, 2021 / Notices from CY 2020 to CY 2021, and such that no area has a factor less than one. For PHAs operating in multiple FMR areas, HUD calculates a voucher-weighted average inflation factor based on the count of vouchers in each FMR area administered by the PHA as captured in HUD administrative data as of December 31, 2020. National Environmental Policy Act of 1969 (42 U.S.C. 4321). III. The Use of Inflation Factors DEPARTMENT OF JUSTICE HUD subsequently applies the calculated individual area inflation factors to eligible renewal funding for each PHA based on VMS leasing and cost data for the prior calendar year. Drug Enforcement Administration jbell on DSKJLSW7X2PROD with NOTICES Drug Enforcement Administration, Justice. ACTION: Notice of application; correction. AGENCY: VI. Environmental Impact This notice involves a statutorily required establishment of a rate or cost determination which does not constitute a development decision affecting the physical condition of specific project areas or building sites. Accordingly, under 24 CFR 50.19(c)(6), this notice is categorically excluded from environmental review under the Jkt 253001 BILLING CODE 4210–67–P Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Lab; Correction As explained above, inflation factors based on area FMR changes are produced for all FMR areas and applied to eligible renewal funding for each PHA. The tables showing the RFIFs, available electronically from the HUD data information page, list the inflation factors for each FMR area on a state-bystate basis. The inflation factors use the same OMB metropolitan area definitions, as revised by HUD, that are used in the FY 2021 FMRs. PHAs should refer to the Area Definitions Table on the following web page to make certain that they are referencing the correct inflation factors: https:// www.huduser.org/portal/datasets/rfif/ FY2021/FY2021_RFIF_FMR_AREA_ REPORT.pdf. The Area Definitions Table lists areas in alphabetical order by state, and the counties associated with each area. In the six New England states, the listings are for counties or parts of counties as defined by towns or cities. HUD is also releasing the data in Microsoft Excel format to assist users who may wish to use these data in other calculations. The Excel file is available at https://www.huduser.gov/portal/ datasets/rfif/rfif.html. Note that, as described earlier, the actual renewal funding inflation factor applied to agency funding will be the voucherweighted average of the FMR area factors when the PHA operates in multiple areas. 16:52 Mar 15, 2021 [FR Doc. 2021–05365 Filed 3–15–21; 8:45 am] [Docket No. DEA–709] IV. Geographic Areas and Area Definitions VerDate Sep<11>2014 Todd Richardson, General Deputy Assistant Secretary for Policy, Development and Research. The Drug Enforcement Administration (DEA) published a document in the Federal Register of September 14, 2020, concerning a notice of application. The document contained a misspelling (Isotype vs. Isotope). SUPPLEMENTARY INFORMATION: Correction In the Federal Register of September 14, 2020, in FR Doc. 2020–20160 (85 FR 56633), on page 56633–56634, correct all instances of the registrant name to read Cambridge Isotope Lab. William T. McDermott, Assistant Administrator. [FR Doc. 2021–05358 Filed 3–15–21; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–805] Importer of Controlled Substances Application: Purisys, LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Purisys, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. SUMMARY: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 15, 2021. Such persons PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.34(a), this is notice that on February 17, 2021, Purisys, LLC, 1550 Olympic Drive, Athens, Georgia 30601, applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: SUMMARY: DATES: may also file a written request for a hearing on the application on or before April 15, 2021. Marihuana Extract ............. Marihuana ......................... Tetrahydrocannabinols ..... Noroxymorphone .............. Phenylacetone .................. Levorphanol ...................... Thebaine ........................... Poppy Straw Concentrate Tapentadol ........................ 7350 7360 7370 7379 8501 9220 9333 9670 9780 I I I II II II II II II The company plans to import drug code 8501, Phenylacetone and drug code 9670, Poppy Straw Concentrate to bulk manufacture other controlled substances for distribution to its customers. The company plans to import impurities of buprenorphine that have been determined by DEA to be captured under drug code 9333, Thebaine. In reference to drug codes 73760, Marihuana and 7370, Tetrahydrocannabinols the company plans to import a Synthetic Cannabidiol and a Synthetic Tetrahydrocannabinol. No other activity for these drug codes is authorized for this registration. Placement of these drug codes on the company’s registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non- E:\FR\FM\16MRN1.SGM 16MRN1 14472 Federal Register / Vol. 86, No. 49 / Tuesday, March 16, 2021 / Notices the novel coronavirus (COVID–19). Schedule updates, including weatherrelated cancellations, are also available at www.ntsb.gov. The National Transportation Safety Board is holding this meeting under the Government in the Sunshine Act, 5 U.S.C. 552(b). approved finished dosage forms for commercial sale. William T. McDermott, Assistant Administrator. [FR Doc. 2021–05356 Filed 3–15–21; 8:45 am] BILLING CODE 4410–09–P NATIONAL CREDIT UNION ADMINISTRATION Dated: March 12, 2021. Candi R. Bing, Federal Register Liaison Officer. Sunshine Act Meetings [FR Doc. 2021–05551 Filed 3–12–21; 4:50 pm] 10:00 a.m., Thursday, March 18, 2021. PLACE: Due to the COVID–19 Pandemic, the meeting will be open to the public via live webcast only. Visit the agency’s homepage (www.ncua.gov) and access the provided webcast link. STATUS: This meeting will be open to the public. MATTERS TO BE CONSIDERED: 1. NCUA Rules and Regulations, Central Liquidity Facility. 2. NCUA Rules and Regulations, Asset Thresholds Pertaining to Large Credit Unions. 3. Board Briefing, NCUA Guaranteed Note and Asset Management Estates Programs. CONTACT PERSON FOR MORE INFORMATION: Melane Conyers-Ausbrooks, Secretary of the Board, Telephone: 703–518–6304. BILLING CODE 7533–01–P TIME AND DATE: Melane Conyers-Ausbrooks, Secretary of the Board. [FR Doc. 2021–05468 Filed 3–12–21; 11:15 am] BILLING CODE 7535–01–P NATIONAL TRANSPORTATION SAFETY BOARD Sunshine Act Meeting 9:30 a.m., Tuesday, April 6, 2021. PLACE: Virtual. STATUS: The one item may be viewed by the public through webcast only. MATTER TO BE CONSIDERED: 66392 2021–2022 Most Wanted List of Transportation Safety Improvements Proposal. FOR MORE INFORMATION CONTACT: Candi Bing at (202) 590–8384 or by email at bingc@ntsb.gov. Media Information Contact: Chris O’Neil by email at chris.oneil@ntsb.gov (202) 314–6100. This meeting will take place virtually. The public may view it through a live or archived webcast by accessing a link under ‘‘Webcast of Events’’ on the NTSB home page at www.ntsb.gov. There may be changes to this event due to the evolving situation concerning jbell on DSKJLSW7X2PROD with NOTICES TIME AND DATE: VerDate Sep<11>2014 16:52 Mar 15, 2021 Jkt 253001 NUCLEAR REGULATORY COMMISSION [Docket Nos. 50–289 and 50–320; NRC– 2021–0069] Exelon Generation Company, LLC; TMI-2 Solutions, LLC; Three Mile Island Nuclear Station, Units 1 and 2 Nuclear Regulatory Commission. ACTION: Exemptions; issuance. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) has issued exemptions in response to a request to reduce the required level of primary offsite liability insurance from $450 million to $100 million and to eliminate the requirement to carry secondary financial protection for Three Mile Island Nuclear Station, Unit 1 and to reduce the required level of primary offsite liability insurance in the event of an extraordinary nuclear occurrence from $200 million to $100 million for Three Mile Island Nuclear Station, Unit 2. DATES: The exemptions were issued on March 9, 2021. ADDRESSES: Please refer to Docket ID NRC–2021–0069 when contacting the NRC about the availability of information regarding this document. You may obtain publicly available information related to this document using any of the following methods: • Federal Rulemaking website: Go to https://www.regulations.gov and search for Docket ID NRC–2021–0069. Address questions about Docket IDs in Regulations.gov to Stacy Schumann; telephone: 301–415–0624; email: Stacy.Schumann@nrc.gov. For technical questions, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publicly available documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ SUMMARY: PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 adams.html. To begin the search, select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301– 415–4737, or by email to pdr.resource@ nrc.gov. The ADAMS accession number for each document referenced (if it is available in ADAMS) is provided the first time that it is mentioned in this document. • Attention: The PDR, where you may examine and order copies of public documents, is currently closed. You may submit your request to the PDR via email at pdr.resource@nrc.gov or call 1–800–397–4209 or 301–415–4737, between 8:00 a.m. and 4:00 p.m. (EST), Monday through Friday, except Federal holidays. FOR FURTHER INFORMATION CONTACT: Theodore Smith, Office of Nuclear Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415–6721, email: Theodore.Smith@ nrc.gov. SUPPLEMENTARY INFORMATION: The text of the exemptions is attached. Dated: March 11, 2021. For the Nuclear Regulatory Commission. Bruce A. Watson, Chief, Reactor Decommissioning Branch, Division of Decommissioning, Uranium Recovery and Waste Programs, Office of Nuclear Material Safety and Safeguards. Attachment—Exemption NUCLEAR REGULATORY COMMISSIOIN Docket Nos. 50–289 and 50–320 Exelon Generation Company, LLC TMI-2 Solutions, LLC Three Mile Island Nuclear Station, Units 1 and 2 Exemptions I. Background By letter dated June 20, 2017 (Agencywide Documents Access and Management System [ADAMS] Accession No. Main Library [ML] ML17171A151), Exelon Generation Company, LLC (Exelon) certified to the U.S. Nuclear Regulatory Commission (NRC, the Commission) that it planned to permanently cease power operations at Three Mile Island Nuclear Station, Unit 1 (TMI-1) on or about September 30, 2019. On September 20, 2019, Exelon permanently ceased power operations at TMI-1. By letter dated September 26, 2019 (ADAMS Accession No. ML19269E480), Exelon certified to the NRC that the fuel was permanently removed from the TMI-1 reactor vessel and placed in the spent fuel pool (SFP) as of September 26, 2019. Accordingly, E:\FR\FM\16MRN1.SGM 16MRN1

Agencies

[Federal Register Volume 86, Number 49 (Tuesday, March 16, 2021)]
[Notices]
[Pages 14471-14472]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-05356]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-805]


Importer of Controlled Substances Application: Purisys, LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Purisys, LLC has applied to be registered as an importer of 
basic class(es) of controlled substance(s). Refer to Supplementary 
Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before April 15, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before April 15, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on February 17, 2021, Purisys, LLC, 1550 Olympic Drive, 
Athens, Georgia 30601, applied to be registered as an importer of the 
following basic class(es) of controlled substance(s):

------------------------------------------------------------------------
 
------------------------------------------------------------------------
Marihuana Extract.....................       7350  I
Marihuana.............................       7360  I
Tetrahydrocannabinols.................       7370  I
Noroxymorphone........................       7379  II
Phenylacetone.........................       8501  II
Levorphanol...........................       9220  II
Thebaine..............................       9333  II
Poppy Straw Concentrate...............       9670  II
Tapentadol............................       9780  II
------------------------------------------------------------------------

    The company plans to import drug code 8501, Phenylacetone and drug 
code 9670, Poppy Straw Concentrate to bulk manufacture other controlled 
substances for distribution to its customers. The company plans to 
import impurities of buprenorphine that have been determined by DEA to 
be captured under drug code 9333, Thebaine. In reference to drug codes 
73760, Marihuana and 7370, Tetrahydrocannabinols the company plans to 
import a Synthetic Cannabidiol and a Synthetic Tetrahydrocannabinol. No 
other activity for these drug codes is authorized for this 
registration. Placement of these drug codes on the company's 
registration does not translate into automatic approval of subsequent 
permit applications to import controlled substances.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-

[[Page 14472]]

approved finished dosage forms for commercial sale.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-05356 Filed 3-15-21; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.